Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JOHNSON & JOHNSONJNJ · Entity 2722 | Exec VP, CFO | February 13, 2026 | February 19, 2026 |
| Kenvue Inc.KVUE · Entity 3098 | Director | May 23, 2024 | May 28, 2024 |
| PRUDENTIAL FINANCIAL INCPRU · Entity 148 | Director | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JOHNSON & JOHNSON
Report date February 13, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,000 |
Ending reported balance
After 2026-02-17 transaction · row 15
15 source rows · reconciled sequenceRow 1 · 2026-02-13 · Exercise / conversion · Acquired 37,463 · Balance 51,463 F1: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. Row 2 · 2026-02-13 · Tax withholding · Disposed 15,948 · Balance 35,515 F2: Shares withheld for payment of taxes upon vesting of PSUs. Row 3 · 2026-02-13 · Exercise / conversion · Acquired 1,779 · Balance 37,294 F3: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Row 4 · 2026-02-13 · Tax withholding · Disposed 507 · Balance 36,787 F4: Shares withheld for payment of taxes upon vesting of RSUs. Row 5 · 2026-02-15 · Exercise / conversion · Acquired 1,971 · Balance 38,758 F5: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Row 6 · 2026-02-15 · Tax withholding · Disposed 858 · Balance 37,900 F4: Shares withheld for payment of taxes upon vesting of RSUs. Row 7 · 2026-02-15 · Exercise / conversion · Acquired 1,878 · Balance 39,778 F6: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Row 8 · 2026-02-15 · Tax withholding · Disposed 817 · Balance 38,961 F4: Shares withheld for payment of taxes upon vesting of RSUs. Row 9 · 2026-02-17 · Exercise / conversion · Acquired 19,241 · Balance 58,202 Row 10 · 2026-02-17 · Sale · Disposed 19,241 · Balance 38,961 F7: This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 11 · 2026-02-17 · Exercise / conversion · Acquired 12,066 · Balance 51,027 Row 12 · 2026-02-17 · Sale · Disposed 12,066 · Balance 38,961 F8: This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 13 · 2026-02-17 · Exercise / conversion · Acquired 33,386 · Balance 72,347 Row 14 · 2026-02-17 · Sale · Disposed 33,386 · Balance 38,961 F9: This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 15 · 2026-02-17 · Sale · Disposed 24,961 · Balance 14,000 F10: This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-13 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2026-02-13 · Exercise / conversion · Disposed 37,463 · Balance 0 F1: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-13 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2026-02-13 · Exercise / conversion · Disposed 1,779 · Balance 0 F3: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 1,971 |
Reported balance
After 2026-02-15 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2026-02-15 · Exercise / conversion · Disposed 1,971 · Balance 1,971 F5: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F13: Each RSU represents a contingent right to receive one share of Company Common Stock. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 3,754 |
Reported balance
After 2026-02-15 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2026-02-15 · Exercise / conversion · Disposed 1,878 · Balance 3,754 F6: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F13: Each RSU represents a contingent right to receive one share of Company Common Stock. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 3,863 |
Reported balance
After 2026-02-15 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2026-02-15 · Grant · Acquired 3,863 · Balance 3,863 F15: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F13: Each RSU represents a contingent right to receive one share of Company Common Stock. |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $243.45 · Expires 2036-02-15 | Direct | 53,793 |
Reported balance
After 2026-02-15 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2026-02-15 · Grant · Acquired 53,793 · Balance 53,793 F14: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $115.67 · Expires 2027-02-13 | Direct | 0 |
Reported balance
After 2026-02-17 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2026-02-17 · Exercise / conversion · Disposed 19,241 · Balance 0 F16: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $129.51 · Expires 2028-02-11 | Direct | 0 |
Reported balance
After 2026-02-17 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2026-02-17 · Exercise / conversion · Disposed 12,066 · Balance 0 F16: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $131.94 · Expires 2029-02-12 | Direct | 33,000 |
Reported balance
After 2026-02-17 transaction · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · 2026-02-17 · Exercise / conversion · Disposed 33,386 · Balance 33,000 F16: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | IndirectBy SLAT | 68,835 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 16
Holding and transaction disclosures are not merged.
1 source rowRow 16 · Balance 68,835 F11: Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary. |
| Common StockSEC Table I · non-derivative | IndirectBy 401k | 2,173 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 17
Holding and transaction disclosures are not merged.
1 source rowRow 17 · Balance 2,173 F12: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026). |
Filing footnotes · ownership attribution and instrument terms
F1: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.
F2: Shares withheld for payment of taxes upon vesting of PSUs.
F3: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
F4: Shares withheld for payment of taxes upon vesting of RSUs.
F5: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
F6: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
F7: This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8: This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9: This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10: This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F11: Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.
F12: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
F13: Each RSU represents a contingent right to receive one share of Company Common Stock.
F14: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
F15: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
F16: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.
Kenvue Inc.
Report date May 23, 2024 · Filed May 28, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 17,188.543 |
Reported balance
After 2024-05-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-05-23 · Grant · Acquired 9,259 · Balance 17,188.543 F1: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2: Includes DSUs acquired as dividend equivalents. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date).
F2: Includes DSUs acquired as dividend equivalents.
PRUDENTIAL FINANCIAL INC
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 9/30/25 Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,826 |
Reported balance
After 2026-09-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-10 · Grant · Acquired 21 · Balance 1,826 F1: Each restricted stock unit represents a contingent right to receive one share of PRU common stock. F2: The restricted stock units vest on September 30, 2026 and were deferred until retirement from the Board under the Prudential Financial, Inc. 2011 Deferred Compensation Plan for Non-Employee Directors. |
| 2026 Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,798 |
Reported balance
After 2026-09-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-10 · Grant · Acquired 21 · Balance 1,798 F1: Each restricted stock unit represents a contingent right to receive one share of PRU common stock. F3: The restricted stock units vest the earlier of the annual meeting or in one year on May 12, 2027 and were deferred until retirement from the Board under the Prudential Financial, Inc. 2011 Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of PRU common stock.
F2: The restricted stock units vest on September 30, 2026 and were deferred until retirement from the Board under the Prudential Financial, Inc. 2011 Deferred Compensation Plan for Non-Employee Directors.
F3: The restricted stock units vest the earlier of the annual meeting or in one year on May 12, 2027 and were deferred until retirement from the Board under the Prudential Financial, Inc. 2011 Deferred Compensation Plan for Non-Employee Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2025 Filed Feb 19, 2025 02:13 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:35 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPerformance Share Units · Derivative | 15,316 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000031 · wk-form4_1739403336.xml · derivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,316 Underlying: Common Stock · 15,316 shares Expires not disclosed F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 00:40 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 13,015 | $100.06 Strike: $100.06 | $1,302,280.90 |
DisclosureSEC source: 0000200406-25-000012 · wk-form4_1739320809.xml · derivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,015 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Reflects the exercise of options immediately prior to their expiration. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 00:40 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 13,015 | $153.89 | $2,002,878.35 |
DisclosureSEC source: 0000200406-25-000012 · wk-form4_1739320809.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: This transaction was executed in multiple trades at prices ranging from $153.86 to $153.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 00:40 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 13,015 | $100.06 | $1,302,280.90 |
DisclosureSEC source: 0000200406-25-000012 · wk-form4_1739320809.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the exercise of options immediately prior to their expiration. Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 22:18 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon Stock | 68,835 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-24-000090 · wk-form4_1729549096.xml · nonDerivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Indirect · By SLAT Disclosed balance after: 68,835 F1 · ownership.nature: Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary. Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 22:18 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon Stock | 68,835 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-24-000090 · wk-form4_1729549096.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 23, 2024 Filed May 28, 2024 21:27 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantDeferred Share Units · Derivative | 9,259 | $19.44 | $179,994.96 |
DisclosureSEC source: 0001944048-24-000123 · wk-form4_1716931671.xml · derivative · entry 1 Wolk Joseph J · CIK 0001744564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,188.543 Underlying: Common Stock · 9,259 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 22, 2024 Filed Oct 21, 2024 22:18 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon Stock | 55 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-24-000090 · wk-form4_1729549096.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,835 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002538 · doc4.xml · derivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,913 Underlying: Common Stock · 5,913 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 95,197 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002538 · doc4.xml · derivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,197 Underlying: Common Stock · 95,197 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 1,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002182 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,558 Underlying: Common Stock · 1,780 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 773 | $157.85 | $122,018.05 |
DisclosureSEC source: 0001225208-24-002182 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,890 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 1,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002182 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 22,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002104 · doc4.xml · derivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,119 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 10,816 | $157.40 | $1,702,438.40 |
DisclosureSEC source: 0001225208-24-002104 · doc4.xml · nonDerivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,883 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 3,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002104 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 22,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002104 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001898 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 1,047 | $156.33 | $163,677.51 |
DisclosureSEC source: 0001225208-24-001898 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,864 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. F3 · balance_after: Reflects an adjustment to the total number of shares previously reported by the reporting person after a reconciliation of such person's ownership records. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001898 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:35 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000064 · wk-form4_1693002935.xml · derivative · entry 2 Wolk Joseph J · CIK 0001744564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F2 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:35 UTC | Kenvue Inc. KVUE · Entity 3098 | OtherCommon Stock | 538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-23-000064 · wk-form4_1693002935.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 538 F1 · price: On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:07 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Disposition to issuerCommon Stock | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008458 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,275.204 F1 · kind: The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock. F2 · price: On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| May 24, 2023 Filed May 25, 2023 20:52 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon Stock | 55 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-006233 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,342.204 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · derivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,338 Underlying: Common Stock · 5,338 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F5 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 88,334 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,334 Underlying: Common Stock · 88,334 shares Expires 2033-02-13 F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 8,578 | $162.01 | $1,389,721.78 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,397.204 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 20,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002067 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,975.204 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001908 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,449 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 979 | $162.08 | $158,676.32 |
DisclosureSEC source: 0001225208-23-001908 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,282.204 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001908 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,261.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 12,926 | $0.00 Strike: $90.44 | $0.00 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · derivative · entry 9 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,926 shares Expires 2024-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 1,855 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · derivative · entry 8 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,855 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 12,926 | $179.62 | $2,321,755.19 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 6 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,812.204 F1 · price: This transaction was executed in multiple trades at prices ranging from $179.610 to $179.670. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 1,855 | $179.46 | $332,905.72 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,738.204 Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 1,855 | $72.54 | $134,561.70 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,593.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 12,926 | $90.44 | $1,169,027.44 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,738.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon Stock | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,812.204 Read SEC document |
| April 20, 2022 Filed Dec 15, 2022 21:34 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,840.204 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 17,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002375 · doc4.xml · derivative · entry 6 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 Underlying: Common Stock · 17,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. F6 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 7,319 | $165.89 | $1,214,148.91 |
DisclosureSEC source: 0001225208-22-002375 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,858.204 F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 17,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002375 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,177.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002218 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 921 | $168.85 | $155,510.85 |
DisclosureSEC source: 0001225208-22-002218 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,384.204 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002218 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,305.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 4,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002375 · doc4.xml · derivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,014 Underlying: Common Stock · 4,014 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 79,280 | $165.89 | $13,151,759.20 |
DisclosureSEC source: 0001225208-22-002375 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,280 Underlying: Common Stock · 79,280 shares Expires 2032-02-14 F4 · security: Awarded under Issuer's Long-Term Incentive Plan. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 2,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002857 · doc4.xml · derivative · entry 7 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,543 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 2,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002857 · doc4.xml · derivative · entry 6 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,543 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.